Cargando…
Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice
This study aimed to investigate the dose–response effect of Bifidobacterium breve CCFM683 on relieving psoriasis and its underlying patterns. Specifically, the expression of keratin 16, keratin 17, and involucrin were substantially decreased by administration of 10(9) CFU and 10(10) CFU per day. Mor...
Autores principales: | Chen, Xinqi, Chen, Yang, Stanton, Catherine, Ross, Reynolds Paul, Zhao, Jianxin, Chen, Wei, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143451/ https://www.ncbi.nlm.nih.gov/pubmed/37111171 http://dx.doi.org/10.3390/nu15081952 |
Ejemplares similares
-
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
por: Li, Tiantian, et al.
Publicado: (2022) -
Bifidobacterium breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial
por: Lan, Yuming, et al.
Publicado: (2023) -
Characterization of CRISPR-Cas systems in Bifidobacterium breve
por: Han, Xiao, et al.
Publicado: (2022) -
Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice
por: Tian, Peijun, et al.
Publicado: (2020) -
Bifidobacterium bifidum CCFM1163 Alleviated Cathartic Colon by Regulating the Intestinal Barrier and Restoring Enteric Nerves
por: Tang, Nan, et al.
Publicado: (2023)